SECTION 3: GUIDELINES FOR REASONABLE ADJUSTMENTS—BRIEF VERSION
INTRODUCTION
Pearson VUE is committed to ensuring access to testing programs for all individuals with disabilities.
Pearson VUE provides reasonable adjustments to individuals with documented disabilities who
demonstrate a need for such. For example, applicants with documented medical, sensory, motor,
psychiatric or learning conditions may request extra testing time or a separate testing room. It is
essential that the documentation provide a clear explanation of the current functional limitation and
a rationale for the requested adjustments.
DETAILED DOCUMENTATION GUIDELINES
All candidates who are requesting reasonable adjustments must provide current documentation
stating their disability and rationale for the requested adjustments.
How old is your supporting documentation?
DISABILITY CATEGORY ................................................ MAXIMUM AGE OF DOCUMENTATION
Learning and other Cognitive Disorders (dyslexia)……………………………............. 5 Years
Attention-Deficit/Hyperactivity Disorder (ADD/ADHD)……… .......................... 5 Years
Psychological and Psychiatric Disorders..................................................... 1 Year
Physical Disorders and Chronic Health Conditions....................................... 1 Year
One or more of the following documents should be submitted with the
applicant’s request form:
Educational or psychological report
Current or recent school-based special education plan
Detailed letter from a qualified professional that describes the disabling condition,
functional limitations, and rationale for the requested adjustments
Any documentation that is submitted must:
Include a clear diagnosis
Be printed on the evaluator’s or school’s official letterhead
Be signed and dated by the evaluator, doctor, or school official
Provide information on current functional limitations that are likely to affect the
candidate’s ability to take the exam under standard conditions
Provide a specific rationale for each requested adjustment
Effective 2/13/20